P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS.

P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS.

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	A. Puła, P. Robak, D. Jarych, D. Mikulski, I. Dróżdż, J. Szemraj, T. Robak
Формат:	Өгүүллэг
Хэл сонгох:	English
Хэвлэсэн:	Wiley 2022-06-01
Цуврал:	HemaSphere
Онлайн хандалт:	http://journals.lww.com/10.1097/01.HS9.0000846352.00706.35

Ижил төстэй зүйлс

Cytokine and Chemokine Profile in Patients with Multiple Myeloma Treated with Bortezomib
-н: Paweł Robak, зэрэг
Хэвлэсэн: (2020-01-01)

High serum level of endostatin in multiple myeloma at diagnosis but not in the plateau phase after treatment
-н: Halina Urbanska-Rys, зэрэг
Хэвлэсэн: (2003-01-01)

The prognostic value of the platelet-to-lymphocyte ratio in multiple myeloma patients treated with a bortezomib-based regimen
-н: Quane Zhang, зэрэг
Хэвлэсэн: (2025-01-01)

Survival and Prognosis Analysis of Bortezomib Based Regimen in Newly Diagnosed Super-aged Multiple Myeloma Patients
-н: ZHAO Fengyi, LI Xin, ZHAN Xiaokai, ZHANG Jiajia, SHEN Man, TANG Ran, FAN Sibin, HUANG Zhongxia
Хэвлэсэн: (2024-03-01)

Effectiveness and safety of bortezomib-dexamethasone regimen in patients with multiple myeloma: A prospective observational study
-н: Nijisha N, зэрэг
Хэвлэсэн: (2024-08-01)

Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma
-н: Anne Lok, зэрэг
Хэвлэсэн: (2014-03-01)

Bortezomib cumulative dose, efficacy, and tolerability with three different bortezomib-melphalan-prednisone regimens in previously untreated myeloma patients ineligible for high-dose therapy
-н: María-Victoria Mateos, зэрэг
Хэвлэсэн: (2014-06-01)

Results of multiple myeloma treatment with bortezomib
-н: T. I. Pospelova, зэрэг
Хэвлэсэн: (2022-11-01)

Clinical significance of circulating dendritic cells in patients with systemic lupus erythematosus
-н: E. Robak, зэрэг
Хэвлэсэн: (2004-01-01)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
-н: T. Robak, зэрэг
Хэвлэсэн: (1998-01-01)

Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus
-н: Ewa Robak, зэрэг
Хэвлэсэн: (2003-01-01)

EP 3 368 868 Coriolis flowmeter
-н: Henry, MP
Хэвлэсэн: (2020)

PB1957: CIRCULATING MIRNA-16 AND MIRNA -21 EXPRESSION LEVELS IN MYELOMA; PRELIMINARY RESULTS.
-н: A.-I. Gkioka, зэрэг
Хэвлэсэн: (2022-06-01)

Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
-н: Dong Liang, зэрэг
Хэвлэсэн: (2024-09-01)

Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens
-н: Juan Du, зэрэг
Хэвлэсэн: (2011-05-01)

Subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma: subanalysis of patients with renal impairment in the phase III MMY-3021 study
-н: Philippe Moreau, зэрэг
Хэвлэсэн: (2015-05-01)

Treatment of Light Chain Deposition Disease Using Bortezomib-Based Regimen Followed by Thalidomide-Based Regimen in a Saudi Male
-н: Bappa Adamu, зэрэг
Хэвлэсэн: (2016-01-01)

Circulating TCR γδ Cells in the Patients with Systemic Lupus Erythematosus
-н: Ewa Robak, зэрэг
Хэвлэсэн: (1999-01-01)

ORGN 868-Oxidative cyclization to give cis-tetrahydrofurans
-н: Churchill, G, зэрэг
Хэвлэсэн: (2006)

Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma
-н: Heinz Ludwig, зэрэг
Хэвлэсэн: (2007-10-01)

PB1985: CHEMO OR CHEMO-FREE REGIMENS IN HEAVILY PRETREATED MULTIPLE MYELOMA? ROLE OF BENDAMUSTINE-BORTEZOMIB-DEXAMETHASONE (BVD) IN NOVEL AGENTS’ ERA
-н: C. Cerchione, зэрэг
Хэвлэсэн: (2022-06-01)

The role of АВС transporters in drug resistance to bortezomib in multiple myeloma
-н: L. A. Laletina, зэрэг
Хэвлэсэн: (2019-04-01)

Protein profiling in myeloma in vivo; Effects of bortezomib in a mouse model of myeloma
-н: Edwards, C, зэрэг
Хэвлэсэн: (2007)

Clinical Assessment of Bortezomib for Multiple Myeloma in Comparison with Thalidomide
-н: Mitsutoshi Satoh, зэрэг
Хэвлэсэн: (2011-02-01)

Effective response with bortezomib retreatment in relapsed multiple myeloma
-н: Christian Taverna, зэрэг
Хэвлэсэн: (2012-04-01)

Iron increases the susceptibility of multiple myeloma cells to bortezomib
-н: Alessandro Campanella, зэрэг
Хэвлэсэн: (2013-06-01)

Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma
-н: Meletios A. Dimopoulos, зэрэг
Хэвлэсэн: (2015-01-01)

Circulating Total and Active Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinases-1 in Patients with Systemic Lupus Erythomatosus
-н: Ewa Robak, зэрэг
Хэвлэсэн: (2006-01-01)

PB1953: ASSESSMENT OF THE EFFICACY OF BORTEZOMIB-CONTAINING THERAPY REGIMENS DEPENDING ON MAGE-C1 GENE EXPRESSION IN MULTIPLE MYELOMA PATIENTS.
-н: M. Eleonora, зэрэг
Хэвлэсэн: (2022-06-01)

Comment on “Retrospective matched-pairs analysis of bortezomib plus dexamethasone versus bortezomib monotherapy in relapsed multiple myeloma”
-н: Simon J. Harrison, зэрэг
Хэвлэсэн: (2015-09-01)

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
-н: Andrew Spencer, зэрэг
Хэвлэсэн: (2018-12-01)

Bortezomib (Velcade) in combination with dexamethasone eor relapsed or refractory myeloma
-н: S. S. Bessmeltsev, зэрэг
Хэвлэсэн: (2022-11-01)

Herpes zoster in multiple myeloma patients during bortezomib treatment
-н: I. N. Nazarova, зэрэг
Хэвлэсэн: (2014-07-01)

Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma
-н: Chi Zhang, зэрэг
Хэвлэсэн: (2023-11-01)

FLAG Regimen and Bortezomib: A Study of Eight Cases with Relapsed Leukaemia
-н: Afaq Khan, зэрэг
Хэвлэсэн: (2023-12-01)

Peripheral neuropathy induced by subcutaneous bortezomib-based induction therapy for newly diagnosed multiple myeloma
-н: Annamaria Brioli, зэрэг
Хэвлэсэн: (2014-11-01)

Overexpression of OsDUF868.12 enhances salt tolerance in rice
-н: Hao Chen, зэрэг
Хэвлэсэн: (2025-01-01)

Modeling serum M‐protein response for early detection of biochemical relapse in myeloma patients treated with bortezomib, lenalidomide and dexamethasone
-н: Yuki Otani, зэрэг
Хэвлэсэн: (2024-12-01)

Elotuzumab in combination with pomalidomide, bortezomib, and dexamethasone in relapsed and refractory multiple myeloma
-н: Andrew J. Yee, зэрэг
Хэвлэсэн: (2025-03-01)

Effect of bortezomib on the treatment of multiple myeloma: a systematic review protocol
-н: Vania dos Santos Nunes-Nogueira, зэрэг
Хэвлэсэн: (2022-06-01)